Trials / Completed
CompletedNCT04319588
Parasternal Block for Cardiac Surgery
Parasternal Block for Postoperative Analgesia in Cardiac Surgery: a Pilot Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 126 (actual)
- Sponsor
- Campus Bio-Medico University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study examine the effect of Parasternal Intercostal Nerve Blocks with local anesthetic on pain control in patients undergoing non-emergent cardiac surgery in a prospective controlled trial. Half of participants will receive General Anesthesia combined to parasternal block while the other half receive only General Anesthesia.
Detailed description
60 patients undergoing elective cardiac surgery will be enrolled and divided into two groups: 1. Interventional (parasternal group) 2. Case control group The "parasternal group" of patients will receive the pre-operative parasternal block (20 ml of 0.5% Ropivacaine per side) in association with infiltration with local anesthetic of access to thoracic drainage (drainage infiltration with 20 ml of 0.25% Ropivacaine) at the end of the intervention combined to General Anesthesia. The "case control group" will only receive drainage infiltration with local anesthetic and standard intraoperative management with opioids.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Parasternal Block+ Infiltration with local anesthetic of access to thoracic drainage | After induction of general anesthesia we will perform an ultrasound-guided Parasternal Block in association with infiltration with local anesthetic of access to thoracic drainage at the end of the intervention. |
| PROCEDURE | Infiltration with local anesthetic of access to thoracic drainage | Infiltration with local anesthetic of access to thoracic drainage at the end of the intervention. |
Timeline
- Start date
- 2020-03-06
- Primary completion
- 2020-05-09
- Completion
- 2020-05-19
- First posted
- 2020-03-24
- Last updated
- 2023-02-08
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04319588. Inclusion in this directory is not an endorsement.